UK hospital will use MindMaze game to aid stroke recoveryA hospital trust has become the first in the UK to deploy a gaming system developed by Swiss Share XUK hospital will use MindMaze game to aid stroke recoveryhttps://pharmaphorum.com/news/uk-hospital-will-use-mindmaze-game-to-aid-stroke-recovery/
Headspace and Ginger finalise $3bn digital mental health mergerHeadspace and Ginger have completed their $3 billion combination to create Headspace Health, a new frontrunner in the Share XHeadspace and Ginger finalise $3bn digital mental health mergerhttps://pharmaphorum.com/news/headspace-and-ginger-finalise-3bn-digital-mental-health-merger/
Digital therapeutics world first for Big Health in ScotlandUK-based Big Health has passed a digital health milestone after Scotland became the first country to make anxiety Share XDigital therapeutics world first for Big Health in Scotlandhttps://pharmaphorum.com/news/digital-therapeutics-world-first-big-health-scotland/
Alnylam launches digital tool for ATTR amyloidosis patientsAlnylam has been a pioneer in hereditary ATTR amyloidosis, getting approval in 2018 for the first drug to Share XAlnylam launches digital tool for ATTR amyloidosis patientshttps://pharmaphorum.com/news/alnylam-launches-digital-tool-for-aatr-amyloidosis-patients/
Data dive finds cheap diuretic could be Alzheimer’s drugA data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have Share XData dive finds cheap diuretic could be Alzheimer’s drughttps://pharmaphorum.com/news/data-dive-finds-cheap-diuretic-could-be-alzheimers-drug/
Limbix’ digital therapeutic cuts depression symptoms in young peopleLimbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for Share XLimbix’ digital therapeutic cuts depression symptoms in young peoplehttps://pharmaphorum.com/news/limbix-digital-therapeutic-cuts-depression-symptoms-in-young-people/
Twin Health raises $140m for “digital twin” diabetes reversal appThe developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases Share XTwin Health raises $140m for “digital twin” diabetes reversal apphttps://pharmaphorum.com/news/twin-health-raises-140m-for-digital-twin-diabetes-reversal-app/
SOM’s AI-discovered drug shows promise in Huntington’s diseaseA drug originally developed for high blood pressure could find a new use in the treatment of Huntington’s Share XSOM’s AI-discovered drug shows promise in Huntington’s diseasehttps://pharmaphorum.com/news/soms-ai-discovered-drug-shows-promise-in-huntingtons-disease/
AI specialist Exscientia raises $510m in upsized IPO, placingExscientia’s artificial intelligence-based drug discovery engine is still largely unproven, but that hasn’t stopped the company raking in Share XAI specialist Exscientia raises $510m in upsized IPO, placinghttps://pharmaphorum.com/news/ai-specialist-exscientia-raises-510m-in-upsized-ipo-placing/
